fluoxetine has been researched along with HIV Coinfection in 16 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Participants were diagnosed with depressive disorders and randomly assigned to receive directly observed therapy with fluoxetine or a referral to community mental health treatment." | 5.24 | Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trial. ( Bangsberg, DR; Dilley, JW; Grelotti, DJ; Hammer, GP; Karasic, DH; Sorensen, JL; Tsai, AC, 2017) |
| " To determine whether effective depression treatment could reduce the frequency of sexual risk behavior, we analyzed secondary outcome data from a 36-week, two-arm, parallel-design, randomized controlled trial, in which homeless and marginally housed, HIV-infected persons with comorbid depressive disorders were randomized to receive either: (a) directly observed treatment with the antidepressant medication fluoxetine, or (b) referral to a local public mental health clinic." | 5.17 | Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. ( Bangsberg, DR; Charlebois, ED; Dilley, JW; Hammer, GP; Karasic, DH; Mimiaga, MJ; Safren, SA; Sorensen, JL; Tsai, AC, 2013) |
| "We conducted a nonblinded, randomized controlled trial of once-weekly fluoxetine, directly observed for 24 weeks, then self-administered for 12 weeks (n = 137 persons with major or minor depressive disorder or dysthymia)." | 5.17 | Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. ( Bangsberg, DR; Charlebois, ED; Dilley, JW; Hammer, GP; Karasic, DH; Moss, AR; Ragland, K; Sorensen, JL; Tsai, AC, 2013) |
| " Health workers should be mindful of dosing to minimise side effects and considerate of the additional pill burden." | 1.91 | The acceptability of antidepressant treatment in people living with HIV in Malawi: A patient perspective. ( Gaynes, BN; Hosseinipour, MC; Kulisewa, K; Minnick, CE; Mphonda, S; Pence, BW; Sansbury, G; Stockton, MA; Udedi, MM, 2023) |
| "We conclude that screening for and treating depression among PLHIV in SSA with fluoxetine would be effective in improving HIV treatment outcomes and would be highly cost-effective." | 1.62 | Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis. ( Arjmand, IK; Bendavid, E; Brandeau, ML; Zhong, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kulisewa, K | 1 |
| Minnick, CE | 1 |
| Stockton, MA | 1 |
| Gaynes, BN | 1 |
| Hosseinipour, MC | 1 |
| Mphonda, S | 1 |
| Sansbury, G | 1 |
| Udedi, MM | 1 |
| Pence, BW | 1 |
| Zhong, H | 1 |
| Arjmand, IK | 1 |
| Brandeau, ML | 1 |
| Bendavid, E | 1 |
| Tsai, AC | 3 |
| Mimiaga, MJ | 1 |
| Dilley, JW | 3 |
| Hammer, GP | 3 |
| Karasic, DH | 3 |
| Charlebois, ED | 2 |
| Sorensen, JL | 3 |
| Safren, SA | 1 |
| Bangsberg, DR | 3 |
| Wagner, GJ | 1 |
| Ngo, VK | 1 |
| Nakasujja, N | 1 |
| Akena, D | 1 |
| Aunon, F | 1 |
| Musisi, S | 1 |
| Grelotti, DJ | 1 |
| Ragland, K | 1 |
| Moss, AR | 1 |
| Krupitsky, EM | 1 |
| Zvartau, EE | 1 |
| Masalov, DV | 1 |
| Tsoy, MV | 1 |
| Burakov, AM | 1 |
| Egorova, VY | 1 |
| Didenko, TY | 1 |
| Romanova, TN | 1 |
| Ivanova, EB | 1 |
| Bespalov, AY | 1 |
| Verbitskaya, EV | 1 |
| Neznanov, NG | 1 |
| Grinenko, AY | 1 |
| O'Brien, CP | 1 |
| Woody, GE | 1 |
| Judd, FK | 1 |
| Mijch, AM | 1 |
| Cockram, A | 1 |
| Ferrando, SJ | 1 |
| Goldman, JD | 1 |
| Charness, WE | 1 |
| Schwartz, JA | 1 |
| McDaniel, JS | 1 |
| Snowden, H | 1 |
| Woolridge, M | 1 |
| Renfrew, M | 1 |
| DeSilva, KE | 1 |
| Le Flore, DB | 1 |
| Marston, BJ | 1 |
| Rimland, D | 1 |
| Darko, W | 1 |
| Guharoy, R | 1 |
| Rose, F | 1 |
| Lehman, D | 1 |
| Pappas, V | 1 |
| Rosenthal, E | 1 |
| Bodokh, I | 1 |
| Chichmanian, RM | 1 |
| Pesce, A | 1 |
| Vinti, H | 1 |
| Reboulot, B | 1 |
| Cassuto, JP | 1 |
| Fernandez, F | 1 |
| Levy, JK | 1 |
| Perkins, DO | 1 |
| Evans, DL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Depression Treatment to Improve Antiretroviral Adherence[NCT00338767] | Phase 2 | 150 participants (Actual) | Interventional | 2001-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fluoxetine and HIV Coinfection
| Article | Year |
|---|---|
Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antidepressive Agents; Anxiety Disorders; Bupropion; Depr | 1991 |
6 trials available for fluoxetine and HIV Coinfection
| Article | Year |
|---|---|
Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Depression; Female; Fluoxetine; Follow | 2013 |
Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Ill-H | 2017 |
Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial.
Topics: Adult; Anti-Retroviral Agents; Antidepressive Agents, Second-Generation; CD4 Lymphocyte Count; CD4-P | 2013 |
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Dru | 2006 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Di | 1997 |
Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study.
Topics: Adult; Depressive Disorder; Desipramine; Double-Blind Method; Female; Fluoxetine; HIV Infections; Hu | 1999 |
9 other studies available for fluoxetine and HIV Coinfection
| Article | Year |
|---|---|
The acceptability of antidepressant treatment in people living with HIV in Malawi: A patient perspective.
Topics: Amitriptyline; Antidepressive Agents; Depression; Fluoxetine; HIV Infections; Humans; Malawi; Pilot | 2023 |
Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis.
Topics: Adult; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Depression; | 2021 |
Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda.
Topics: Adult; Antidepressive Agents; Cognition Disorders; Condoms; Depressive Disorder, Major; Developing C | 2014 |
Fluoxetine treatment of depressed patients with HIV infection.
Topics: Adjustment Disorders; Adult; Antidepressive Agents, Second-Generation; Antiviral Agents; Depressive | 1995 |
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Topics: Drug Therapy, Combination; Female; Fluoxetine; Galactorrhea; HIV Infections; HIV Protease Inhibitors | 2001 |
Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine.
Topics: Adult; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Cytochrome P-450 Enzyme System; De | 2001 |
Myoclonus secondary to the concurrent use of trazodone and fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Drug Synergism; Fluoxetine; HIV Infecti | 2001 |
[Lyell's syndrome in 2 HIV infected patients. Sulfamides are not the only culprits].
Topics: Acquired Immunodeficiency Syndrome; Adult; Chlormezanone; Fluoxetine; HIV Infections; Humans; Male; | 1991 |
Fluoxetine treatment of depression in patients with HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Depressive Disorder; Fluoxetine; HIV Infections; Humans; | 1991 |